Page 1 of Clinical Trials for HDAC inhibitors, 356 Total Matches
- 1CompletedSafety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid TumoursLast Updated: November 25, 2011Condition(s): Solid Tumor
- 2RecruitingLast Updated: May 18, 2012Condition(s): Cutaneous T-cell Lymphoma; Histone Deacetylase Inhibitor; Lymphoma; Oncology
- 3TerminatedLast Updated: July 20, 2011Condition(s): Breast Cancer
- 4TerminatedLast Updated: February 1, 2012Condition(s): Hodgkin's Lymphoma
- 5CompletedLast Updated: April 17, 2012Condition(s): Relapsed or Refractory Multiple Myeloma
- 6CompletedLast Updated: January 31, 2012Condition(s): Myeloproliferative Diseases
- 7RecruitingLast Updated: April 19, 2012Condition(s): Clear Cell Renal Cell Carcinoma; Recurrent Renal Cell Cancer; Stage III Renal Cell Cancer; Stage IV Renal Cell Cancer
- 8Not yet recruitingLast Updated: March 1, 2012Condition(s): HDAC Activity
- 9CompletedLast Updated: March 29, 2012Condition(s): Lymphoma
- 10TerminatedLast Updated: July 18, 2011Condition(s): Chronic Lymphocytic Leukemia
- 11RecruitingLast Updated: April 8, 2012Condition(s): Gastric Cancer; Histone Deacetylase Inhibitor
- 12TerminatedLast Updated: February 1, 2012Condition(s): Chronic Lymphocytic Leukemia
- 13RecruitingLast Updated: June 5, 2009Condition(s): Advanced Breast Cancer
- 14CompletedLast Updated: November 25, 2011Condition(s): Hematological Disease; Lymphoid Malignancies
- 15RecruitingLast Updated: June 22, 2010Condition(s): Non-small Cell Lung Cancer; Pancreatic Cancer; Melanoma; Lymphoma
- 16RecruitingLast Updated: February 16, 2012Condition(s): Advanced Hematologic Malignancies
- 17RecruitingLast Updated: December 5, 2011Condition(s): Graft-Versus-Host Disease
- 18Active, not recruitingLast Updated: December 9, 2011Condition(s): Polycythemia Vera; Essential Thrombocythemia
- 19CompletedLast Updated: January 31, 2012Condition(s): Hodgkin's Lymphoma
- 20Active, not recruitingLast Updated: October 11, 2011Condition(s): Multiple Myeloma
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=HDAC+inhibitors
